Vascular Graft Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
The Global Vascular Graft Market, valued at USD 3.6 billion in 2024, is set to witness impressive growth, with a projected CAGR of 6.9% from 2025 to 2034. This robust expansion is driven by multiple factors, including the escalating prevalence of cardiovascular diseases, rising occurrences of end-stage renal disease (ESRD), and increasing surgical interventions. Furthermore, technological advancements in vascular grafts and the shift toward minimally invasive procedures are transforming the landscape, enhancing patient outcomes, and making surgical solutions more accessible and effective.
As healthcare systems worldwide grapple with aging populations and the associated rise in chronic conditions, the demand for vascular grafts continues to surge. Innovations in bioengineered and synthetic graft materials are addressing critical challenges such as biocompatibility, durability, and ease of use. Hybrid grafts, which combine the strengths of multiple materials, are also gaining traction for their ability to improve surgical success rates. With a greater emphasis on personalized healthcare, manufacturers invest in research and development to create next-generation grafts tailored to diverse medical needs, ensuring the market remains dynamic and competitive.
The market is segmented by raw material into polyester grafts, expanded polytetrafluoroethylene (EPTFE) grafts, biosynthetic grafts, and polyurethane grafts. Polyester grafts are positioned to dominate, with an anticipated CAGR of 7.3%, driving their market value to USD 4.7 billion by 2034. These grafts, often constructed from materials like Dacron, are lauded for their strength and longevity, particularly in high-pressure vascular environments. Their widespread application in repairing large vessels and addressing complex cardiovascular challenges highlights their critical role in the market's growth.
By application, vascular grafts are utilized in procedures such as endovascular aneurysm repair (EVAR), hemodialysis access, and peripheral vascular repair. Among these, EVAR is poised for remarkable growth, with a projected CAGR of 7.7%, reaching USD 3.5 billion by 2034. This minimally invasive approach, characterized by smaller incisions and shorter recovery periods, is increasingly favored over traditional open surgeries. Its reduced risk of complications makes it an ideal solution for elderly and high-risk patients, significantly boosting its adoption globally.
In North America, the vascular graft market is projected to grow at a CAGR of 6.1% from 2025 to 2034, starting at USD 1.1 billion in 2024. The region remains a leader in embracing advanced surgical technologies, including EVAR, which often necessitates specialized grafts like stent grafts. The widespread adoption of cutting-edge medical techniques and a well-established healthcare infrastructure position North America as a key driver of innovation and demand within the global vascular graft market.
As healthcare systems worldwide grapple with aging populations and the associated rise in chronic conditions, the demand for vascular grafts continues to surge. Innovations in bioengineered and synthetic graft materials are addressing critical challenges such as biocompatibility, durability, and ease of use. Hybrid grafts, which combine the strengths of multiple materials, are also gaining traction for their ability to improve surgical success rates. With a greater emphasis on personalized healthcare, manufacturers invest in research and development to create next-generation grafts tailored to diverse medical needs, ensuring the market remains dynamic and competitive.
The market is segmented by raw material into polyester grafts, expanded polytetrafluoroethylene (EPTFE) grafts, biosynthetic grafts, and polyurethane grafts. Polyester grafts are positioned to dominate, with an anticipated CAGR of 7.3%, driving their market value to USD 4.7 billion by 2034. These grafts, often constructed from materials like Dacron, are lauded for their strength and longevity, particularly in high-pressure vascular environments. Their widespread application in repairing large vessels and addressing complex cardiovascular challenges highlights their critical role in the market's growth.
By application, vascular grafts are utilized in procedures such as endovascular aneurysm repair (EVAR), hemodialysis access, and peripheral vascular repair. Among these, EVAR is poised for remarkable growth, with a projected CAGR of 7.7%, reaching USD 3.5 billion by 2034. This minimally invasive approach, characterized by smaller incisions and shorter recovery periods, is increasingly favored over traditional open surgeries. Its reduced risk of complications makes it an ideal solution for elderly and high-risk patients, significantly boosting its adoption globally.
In North America, the vascular graft market is projected to grow at a CAGR of 6.1% from 2025 to 2034, starting at USD 1.1 billion in 2024. The region remains a leader in embracing advanced surgical technologies, including EVAR, which often necessitates specialized grafts like stent grafts. The widespread adoption of cutting-edge medical techniques and a well-established healthcare infrastructure position North America as a key driver of innovation and demand within the global vascular graft market.
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Industry 360° synopsis
CHAPTER 3 INDUSTRY INSIGHTS
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing number of chronic diseases worldwide
3.2.1.2 Growing number of end-stage renal disorders in developing economies
3.2.1.3 Technological advancements in developed countries
3.2.1.4 Rise in organ transplantation
3.2.2 Industry pitfalls and challenges
3.2.2.1 Lack of skilled personnel in developing countries
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Gap analysis
3.7 Pricing analysis
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 Future market trends
CHAPTER 4 COMPETITIVE LANDSCAPE, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
CHAPTER 5 MARKET ESTIMATES AND FORECAST, BY RAW MATERIAL, 2021 – 2034 ($ MN)
5.1 Key trends
5.2 Polyester grafts
5.3 EPTFE grafts
5.4 Biosynthetic grafts
5.5 Polyurethane grafts
CHAPTER 6 MARKET ESTIMATES AND FORECAST, BY APPLICATION, 2021 – 2034 ($ MN)
6.1 Key trends
6.2 Endovascular aneurysm repair
6.2.1 Abdominal aortic aneurysm repair
6.2.2 Thoracic aortic aneurysm repair
6.3 Hemodialysis access
6.4 Peripheral vascular repair
CHAPTER 7 MARKET ESTIMATES AND FORECAST, BY END USE, 2021 – 2034 ($ MN)
7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Other End Use
CHAPTER 8 MARKET ESTIMATES AND FORECAST, BY REGION, 2021 – 2034 ($ MN)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
CHAPTER 9 COMPANY PROFILES
9.1 Abbott
9.2 ARTIVION
9.3 B. Braun
9.4 BD (Becton, Dickinson & Company)
9.5 Cook Medical
9.6 Cordis
9.7 Endologix
9.8 GETINGE
9.9 LeMaitre
9.10 Medtronic
9.11 MERIT MEDICAL
9.12 MicroPort
9.13 TERUMO
9.14 Vascular Graft Solutions
9.15 GORE
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Industry 360° synopsis
CHAPTER 3 INDUSTRY INSIGHTS
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing number of chronic diseases worldwide
3.2.1.2 Growing number of end-stage renal disorders in developing economies
3.2.1.3 Technological advancements in developed countries
3.2.1.4 Rise in organ transplantation
3.2.2 Industry pitfalls and challenges
3.2.2.1 Lack of skilled personnel in developing countries
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Gap analysis
3.7 Pricing analysis
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 Future market trends
CHAPTER 4 COMPETITIVE LANDSCAPE, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
CHAPTER 5 MARKET ESTIMATES AND FORECAST, BY RAW MATERIAL, 2021 – 2034 ($ MN)
5.1 Key trends
5.2 Polyester grafts
5.3 EPTFE grafts
5.4 Biosynthetic grafts
5.5 Polyurethane grafts
CHAPTER 6 MARKET ESTIMATES AND FORECAST, BY APPLICATION, 2021 – 2034 ($ MN)
6.1 Key trends
6.2 Endovascular aneurysm repair
6.2.1 Abdominal aortic aneurysm repair
6.2.2 Thoracic aortic aneurysm repair
6.3 Hemodialysis access
6.4 Peripheral vascular repair
CHAPTER 7 MARKET ESTIMATES AND FORECAST, BY END USE, 2021 – 2034 ($ MN)
7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Other End Use
CHAPTER 8 MARKET ESTIMATES AND FORECAST, BY REGION, 2021 – 2034 ($ MN)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
CHAPTER 9 COMPANY PROFILES
9.1 Abbott
9.2 ARTIVION
9.3 B. Braun
9.4 BD (Becton, Dickinson & Company)
9.5 Cook Medical
9.6 Cordis
9.7 Endologix
9.8 GETINGE
9.9 LeMaitre
9.10 Medtronic
9.11 MERIT MEDICAL
9.12 MicroPort
9.13 TERUMO
9.14 Vascular Graft Solutions
9.15 GORE
